利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

114 条记录 (耗时 0.038 秒)

    Fraud deterrence for secure transactions
    5.
    发明授权
    Fraud deterrence for secure transactions 有权

    公开(公告)号：US11257080B2

    公开(公告)日：2022-02-22

    申请号：US17201835

    申请日：2021-03-15

    申请人： Michael Sasha John

    发明人： Michael Sasha John

    IPC分类号： G06Q20/40 ,  G06Q30/06 ,  G06Q40/00 ,  G06Q20/12 ,  G06Q20/42 ,  G06F21/32 ,  G06F21/35 ,  G06F21/60 ,  G06F21/62 ,  G06Q20/38

    摘要： An illustrative fraud deterrent method includes presenting an identity verification option for a first website displayed in a web-browser, the option including offering a login to a third-party website, unrelated to the first website. The method further includes receiving login information for a first user account on the third-party website and verifying the login information through a verification service associated with the third-party website, to verify that the login information is valid for the first user account, identified by the login information. The method additionally includes verifying an identity at the first website, responsive to the verification.

    Systems and Methods for Automatic and Transparent Client Authentication and Online Transaction Verfication
    6.
    发明申请
    Systems and Methods for Automatic and Transparent Client Authentication and Online Transaction Verfication 有权

    公开(公告)号：US20210110448A1

    公开(公告)日：2021-04-15

    申请号：US17107629

    申请日：2020-11-30

    申请人： Michael Sasha John

    发明人： Michael Sasha John

    IPC分类号： G06Q30/06 ,  G06Q20/40

    摘要： Systems and methods are described for providing fraud deterrents, detection and prevention during e-commerce, e-transactions, digital rights management and access control. Fraud deterrent levels may be automatically selected by a requesting transaction approval entity server (and can be related to level of risk, or security, related to fraud) or may be selected by a consumer. These deterrent levels can determine the manner in which the transaction occurs as well as the types of information that must be provided and validated for successful approval of the transaction. The client can associate their credit card with a specific device, an e-identity, such as an instant messaging identity, and the e-identity is contacted as a part of finalizing a payment transaction so that a client response of ‘approve’ or ‘reject’ can be obtained. The anti-fraud technology also provides for management and storage of historical transaction information. Entity-to-client communication occurs according to merchant permission parameters which are defined by the client and which enable messages sent by the entity to be automatically allowed, rejected, and managed in other ways as well.

    Systems and methods for automatic and transparent client authentication and online transaction verification
    7.
    发明授权
    Systems and methods for automatic and transparent client authentication and online transaction verification 有权

    公开(公告)号：US10853855B2

    公开(公告)日：2020-12-01

    申请号：US12124144

    申请日：2008-05-20

    申请人： Michael Sasha John

    发明人： Michael Sasha John

    IPC分类号： G06Q30/06 ,  G06Q20/40

    摘要： Systems and methods are described for providing fraud deterrents, detection and prevention during e-commerce, e-transactions, digital rights management and access control. Fraud deterrent levels may be automatically selected by a requesting transaction approval entity server (and can be related to level of risk, or security, related to fraud) or may be selected by a consumer. These deterrent levels can determine the manner in which the transaction occurs as well as the types of information that must be provided and validated for successful approval of the transaction. The client can associate their credit card with a specific device, an e-identity, such as an instant messaging identity, and the e-identity is contacted as a part of finalizing a payment transaction so that a client response of ‘approve’ or ‘reject’ can be obtained. The anti-fraud technology also provides for management and storage of historical transaction information. Entity-to-client communication occurs according to merchant permission parameters which are defined by the client and which enable messages sent by the entity to be automatically allowed, rejected, and managed in other ways as well.

    Medical drug delivery systems with mixing chamber
    8.
    发明授权
    Medical drug delivery systems with mixing chamber 有权

    公开(公告)号：US10589024B2

    公开(公告)日：2020-03-17

    申请号：US15925723

    申请日：2018-03-19

    申请人： Michael Sasha John

    发明人： Michael Sasha John

    IPC分类号： A61M5/168 ,  A61B5/00 ,  A61M5/142 ,  A61M5/172 ,  A61M25/00 ,  G06F19/00 ,  A61M5/14 ,  G16H20/17 ,  A61B5/145

    摘要： A drug delivery system provides for controlled mixing of drugs, using at least one mixing chamber. Flow controllers guide drugs into single or multiple catheters, enabling a single lumen catheter to dispense multiple drugs, diluting a concentrated drug to provide varying drug concentration. A buffer fluid can deliver precise drug amounts or can separate drugs within a catheter. A patient's bodily fluid can serve as a diluent or buffer fluid. A drug testing/filler apparatus may be used to facilitate filling of multiple reservoirs. Bolus or continuous delivery of drug to selected distal locations can occur at independent rates. New catheter systems, hub assemblies, and uses therefore are also described. New methods for promotion of healthy pregnancy and treatment of a developing fetus are disclosed.

    Systems and methods for vector stimulation in medical treatment
    9.
    发明授权
    Systems and methods for vector stimulation in medical treatment 有权

    公开(公告)号：US10322294B2

    公开(公告)日：2019-06-18

    申请号：US14474289

    申请日：2014-09-01

    申请人： Michael Sasha John

    发明人： Michael Sasha John

    IPC分类号： A61N1/05 ,  A61N2/00 ,  A61N1/36 ,  A61N2/02

    摘要： Stimulation treatments for medical disorders comprise providing stimulation parameters that create partial stimulation signals which combine into vector signals. The individual partial signals may have frequency or temporal content that is unique rather than all being identical. Vector signals may thus be designed with certain advantageous characteristics such as to influence target tissue in an intended manner while partial signals may be designed with other advantageous characteristics such as to avoid producing side effects in adjacent tissue. Roving of stimulation parameters can be designed to influence partial signals, vectors signals, or both. Partial and vector signals may be designed to match or avoid internal/endogenous activity patterns and rhythms of a patient. Methods for choosing, creating and using partial signals are disclosed. Tissue modulation may be accomplished with electrical and/or magnetic stimulation.

    Systems and Methods for Improved Spinal Cord Stimulation
    10.
    发明申请
    Systems and Methods for Improved Spinal Cord Stimulation 审中-公开

    公开(公告)号：US20190134402A1

    公开(公告)日：2019-05-09

    申请号：US16241524

    申请日：2019-01-07

    申请人： Michael Sasha John

    发明人： Michael Sasha John

    IPC分类号： A61N1/36 ,  A61N1/372

    CPC分类号： A61N1/36178 ,  A61M5/14276 ,  A61M5/172 ,  A61M5/1723 ,  A61N1/0456 ,  A61N1/0529 ,  A61N1/36064 ,  A61N1/36071 ,  A61N1/36082 ,  A61N1/36114 ,  A61N1/37235

    摘要： Stimulation treatments for various medical disorders, such as neurological disorders, comprise novel systems, strategies, and methods for providing TMS, electrical, magnetic, optical and other stimulation modalities. Some stimulation methods comprise varying the stimulation parameters to improve the therapeutic efficacy of stimulation, and decrease risk of habituation and side-effects such as interference with normal brain, sensory, motor, and cognitive processes. The creation, and subsequent variation, of stimulation parameters can use sensed data in order to match, adjust, or avoid matching characteristics of the stimulation therapy relative to certain endogenous brain activities. Novel methods are described for choosing, creating and subsequently stimulating with partial signals which summate to produce therapeutic vector fields having unique temporal patterns and low- or high-frequency spectral content. Improvements for the treatment of pain are disclosed.